Company profilePharmaceutical#911 of 1,318 in Pakistan1 DRAP alert

CKD PHARMA

Pharmaceutical company · 6 brands · 7 molecules

Ranked #1 of 1 companies in Erectile Dysfunction Products

6 registered products 7 pharmaceutical brands 7 distinct molecules 1 DRAP alert

Company overview

6
registered products
7
pharmaceutical brands
7
distinct molecules
6
therapeutic classes
1
DRAP alerts

CKD PHARMA is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 6 product registrations across 7 distinct molecules. Its portfolio is concentrated in Erectile Dysfunction Products and Vaccine. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by CKD

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Corticosteroid Combinations, Topical 1

Top molecules by brand count

Sildenafil1 brand
Omeprazole1 brand
Diclofenac Sodium Topical1 brand
Neomycin1 brand

Therapeutic classes

Erectile Dysfunction Products · 1Vaccine · 1Other Analgesics And Antipyretics · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Topical Products For Joint And Muscular Pain · 1Corticosteroid Combinations, Topical · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 180 – Rs 180
Median across source: Rs 180

Regulatory record

1 alert in the DRAP feed we track.

106.Recall Alert – (Class-III) Tablet Cekamol 500 mg (Batch # T-5014)
2025-11-12

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 137 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
NABIQASIM INDUSTRIES (PVT) LTD. holds 195 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
AGP (PRIVATE) LTD. holds 142 molecules not in this portfolio
AmikacinAminophyllineAmlodipineAmoxicillinAprepitantArtemether

Get the full profile for CKD

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.